INtranasal OXyTocin for the Treatment of Autism Spectrum Disorders

NCT01788072 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Autism Spectrum Disorder

Interventions

DRUG: Intranasal Oxytocin
DRUG: Placebo

Sponsor

Holland Bloorview Kids Rehabilitation Hospital

Collaborators

[object Object]
[object Object]